Clinical Trials in Hefei, Anhui

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

NCT ID: NCT05126277

This clinical trial is studying a new treatment called ianalumab for adults with active lupus nephritis, a condition where lupus causes inflammation in the kidneys. The trial will compare the effec...

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

NCT ID: NCT06698796

This clinical trial is looking at how a medicine called dazukibart works for people with two muscle disorders known as dermatomyositis (DM) and polymyositis (PM). These conditions cause inflammatio...

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT ID: NCT05671510

This clinical trial is studying a new treatment called gotistobart (ONC-392) for patients with metastatic non-small cell lung cancer (NSCLC) who have not responded to previous treatments using PD-1...

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

NCT ID: NCT05895786

**Clinical Trial Summary: Understanding PF-06823859 for Myositis** This clinical trial is studying a new medicine called PF-06823859 to see how well it works for people with active dermatomyositis...

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

NCT ID: NCT06747455

This clinical trial is studying the use of a medication called Bacillus Calmette-Guérin (BCG) to help prevent the return of non-muscle-invasive bladder cancer after surgery. The trial is specifical...

Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

NCT ID: NCT07050576

This clinical trial is studying a new way to predict whether early-stage esophageal squamous cell carcinoma (a type of throat cancer) has spread to the lymph nodes. The research uses advanced compu...

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

NCT ID: NCT05013190

This clinical trial is studying the medication NINLARO® (also known as ixazomib) in adults with multiple myeloma, a type of blood cancer. The main goal is to see how well this treatment works and w...

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

NCT ID: NCT05949684

The ELEMENT-MDS clinical trial is studying how effective and safe a medication called Luspatercept is for treating anemia in adults with Myelodysplastic Syndromes (MDS) who are not receiving blood ...

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

NCT ID: NCT06993792

This clinical trial is studying a new medication called orforglipron to see how well it works for people who are overweight or have obesity, with or without type 2 diabetes. The goal is to compare ...

A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer

NCT ID: NCT07003074

This clinical trial is testing a new treatment called TQB2102 for patients with HER2 positive recurrent or metastatic breast cancer, which is a type of breast cancer that has returned or spread to ...

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

NCT ID: NCT07047365

This clinical trial is studying a new drug called TQB2930, combined with chemotherapy, to treat advanced breast cancer that tests positive for a protein called HER2. The study will compare this new...

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

NCT ID: NCT06294678

This clinical trial is looking at how the timing of stem cell infusion affects the development of acute graft-versus-host disease (aGVHD) in patients with blood cancers. aGVHD is a condition that c...

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

NCT ID: NCT06294691

This clinical trial is studying how the timing of stem cell infusion affects the development of acute graft-versus-host disease (aGVHD) in patients with certain blood disorders. aGVHD is a conditio...

Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

NCT ID: NCT06707194

This clinical trial is investigating the combined use of Benzathine Penicillin and Etanercept for treating spondyloarthritis, which includes conditions like ankylosing spondylitis. The goal is to s...

TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer

NCT ID: NCT07044908

This clinical trial is studying a new combination of medicines, including a drug called TQB2922 along with TAS-102, with or without another medicine called bevacizumab. The goal is to see if this t...

SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 Expression

NCT ID: NCT07047443

This clinical trial is studying a new combination treatment for women with advanced breast cancer that shows certain levels of a protein called HER2. The trial aims to find the best dose of a drug ...

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

NCT ID: NCT04164199

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT06073821

This clinical trial is studying the effectiveness of two different treatment combinations for people with chronic lymphocytic leukemia (CLL), a type of cancer that affects the blood and bone marrow...

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

NCT ID: NCT06970743

This clinical trial is studying a new treatment called BGB-16673 for patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). These are types of ...

Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease

NCT ID: NCT07031531

This clinical trial is studying a new, technology-based system called SMART-CHD, which uses artificial intelligence (AI) to help manage and improve the care of adults aged 18 to 45 who have prematu...